Featured Research

from universities, journals, and other organizations

"Super" Aspirin And Clot Buster May Prevent Surgery

Date:
June 2, 1999
Source:
American Heart Association
Summary:
Two clot-thinning drugs may be better than one for treating heart attacks, according to results of new study that appears in today's issue of Circulation: Journal of the American Heart Association.

Dallas, June 1 -- Two clot-thinning drugs may be better than one for treating heart attacks, according to results of new study that appears in today's issue of Circulation: Journal of the American Heart Association.

One drug, called a thrombolytic, dissolves blood clots. The second drug, a platelet IIb/IIIa receptor blocker, keeps platelets from clumping and forming the blood clots that can obstruct blood flow and thereby trigger a heart attack or stroke. The platelet blockers, sometimes called "super aspirin" are more potent than aspirin. They are also administered through an intravenous drip or infusion.

According to lead investigator of the study, Elliott Antman, M.D., director of the Coronary Care Unit at Brigham and Women's Hospital, Boston, "The trial tested the hypothesis that the platelet blocker is a potent and safe addition to thrombolytic regimens."

Results of the new study, called the TIMI 14 trial, are so impressive, that researchers say that many individuals with heart attacks who otherwise would require angioplasty or bypass surgery to restore blood flow to the heart may be treated instead with both drugs. Angioplasty involves using a narrow tube with a deflated balloon on its tip that is passed into the narrowed part of the artery. When the balloon is inflated, the blockages or blood clots are pushed aside, allowing blood to flow through. Bypass surgery is an operation that uses blood vessels "borrowed" from another part of the body to go around clogged coronary arteries to reestablish blood flow to the heart.

According to J. Ward Kennedy, M.D., who wrote an accompanying editorial, the investigators have "made a major contribution to the management of acute myocardial infarctions (heart attacks)"-- and identified a therapy, which will likely prove to be equivalent or superior to opening blood vessels with medical procedures such as angioplasty.

The study included 888 individuals who had suffered a heart attack. Patients were treated with one of four therapies; alteplase, alone, abciximab alone or abciximab with reduced doses of alteplase.

Each patient received an angiogram, a visualization of the blood vessels that uses X-rays to determine how quickly the drugs dissolved blood clots in the vessel. The study examined the ability of the drugs to dissolve blood clots within 60 and 90 minutes. The study showed that 72 percent of heart attack victims who received abciximab plus half the standard dose of alteplase achieve optimal blood flow in their arteries within 60 minutes of treatment compared with only 43 percent of patients treated with alteplase alone. Within 90 minutes, 77 percent of patients treated with combination therapy achieved this level of blood flow, compared with 62 percent given alteplase alone.

Clot-buster drugs currently are the standard therapy for treating heart attacks. However, they are not always effective and many individuals develop recurrent blood clots.

"By enhancing the effects of clot-busters, abciximab may improve the treatment for heart attacks, and allow more patients to be treated with drugs rather than angioplasty and surgery," says Antman.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. ""Super" Aspirin And Clot Buster May Prevent Surgery." ScienceDaily. ScienceDaily, 2 June 1999. <www.sciencedaily.com/releases/1999/06/990602072700.htm>.
American Heart Association. (1999, June 2). "Super" Aspirin And Clot Buster May Prevent Surgery. ScienceDaily. Retrieved September 15, 2014 from www.sciencedaily.com/releases/1999/06/990602072700.htm
American Heart Association. ""Super" Aspirin And Clot Buster May Prevent Surgery." ScienceDaily. www.sciencedaily.com/releases/1999/06/990602072700.htm (accessed September 15, 2014).

Share This



More Health & Medicine News

Monday, September 15, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Respiratory Virus Spreads To Northeast, Now In 21 States

Respiratory Virus Spreads To Northeast, Now In 21 States

Newsy (Sep. 14, 2014) The respiratory virus Enterovirus D68, which targets children, has spread from the Midwest to 21 states. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins